New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
08:00 EDTACT, HITK, IPXL, MNK, MNTA, PRGO, RDY, TEVABMO Capital to hold a summit
BMO Generic Drug Summit is being held in Orlando on February 19.
News For ACT;HITK;IPXL;MNK;MNTA;PRGO;RDY;TEVA From The Last 14 Days
Check below for free stories on ACT;HITK;IPXL;MNK;MNTA;PRGO;RDY;TEVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 30, 2014
06:07 EDTIPXLImpax downgraded to Hold from Buy at WallachBeth
Subscribe for More Information
July 29, 2014
12:30 EDTIPXLImpax downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
08:18 EDTIPXLImpax announces FDA performs inspection on Taiwan facility
Impax announced that the FDA performed a general GMP inspection and a Pre-Approval Inspection for RYTARYTM at the company's Taiwan manufacturing facility from July 21 to July 26. At the conclusion of the inspection, the FDA issued a Form 483 with ten inspectional observations. The Taiwan facility was approved for product manufacturing by the FDA in September 2009 and by Taiwan FDA in July 2010. The facility currently manufactures 12 products for distribution in the United States. The FDA did not provide any status or classification to these observations and will wait until they have received and reviewed the company's response to provide this information. The Ccmpany has also not been informed by the FDA of the impact this Form 483 may have on RYTARY's October 9 review date under the Prescription Drug User Fee Act.
July 25, 2014
13:13 EDTMNKEinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
12:18 EDTMNKGreenlight discloses short positions in Safeway, Questcor, Bloomberg says
Subscribe for More Information
07:14 EDTTEVATeva August weekly volatility elevated into Q2 and outlook
Teva August weekly call option implied volatility is at 34, August is at 25, September and January is at 22; compared to its 26-week average of 27 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 31.
July 24, 2014
12:56 EDTPRGOPerrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0%
Subscribe for More Information
07:27 EDTTEVASome of Teva's biggest investors to vote against re-electing directors, WSJ says
Subscribe for More Information
06:45 EDTTEVATeva price target raised to $70 from $65 at Barclays
Subscribe for More Information
July 23, 2014
10:02 EDTACT, TEVA, PRGO, MNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTACT, PRGO, MNK, TEVADeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTPRGOPerrigo initiated with a Buy at Deutsche Bank
Target $189.
16:09 EDTACTActavis initiated with a Buy at Deutsche Bank
Subscribe for More Information
16:09 EDTMNKMallinckrodt initiated with a Buy at Deutsche Bank
Subscribe for More Information
16:08 EDTTEVATeva initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
16:36 EDTACTActavis and Medicines360 announce FDA acceptance of Levosert NDA
Subscribe for More Information
08:11 EDTTEVAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
08:01 EDTTEVATeva completes acquisition of Labrys
Subscribe for More Information
07:36 EDTMNKMallinckrodt price target raised to $95 from $85 at Jefferies
Subscribe for More Information
July 18, 2014
09:35 EDTPRGOPerrigo would rather make acquisitions than be sold, dealReporter says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use